Literature DB >> 14691915

Surgical pathology of pulmonary thromboendarterectomy: a study of 54 cases from 1990 to 2001.

Lori A Blauwet1, William D Edwards, Henry D Tazelaar, Christopher G A McGregor.   

Abstract

Thromboendarterectomy is performed to treat chronic thromboembolic pulmonary hypertension with obstruction of main, lobar, or segmental pulmonary arteries. The present study evaluated surgical specimens removed between 1990 and 2001. Medical histories and microscopic slides were reviewed in each case. Study slides were stained with hematoxylin and eosin and Verhoeff-van Gieson and evaluated for thrombus, collagen, elastin, atherosclerosis, hemosiderin, calcification, and inflammation. The study group comprised 54 patients (30 women and 24 men), ranging in age from 33 to 77 years (mean, 58 years). Clinically, 28 (52%) had a history of deep leg vein thrombosis and 42 (78%) had a history of pulmonary embolism; 24 (44%) had both events. Coagulation abnormalities were documented in 15 (28%); autoimmune or hematologic disorders, in 8 (15%). Pulmonary thromboendarterectomy was bilateral in 52 patients (96%) and right-sided in 2. Six patients also had obstructions resected from the main pulmonary arteries. Obstruction limited to segmental arteries occurred only in women. Grossly, right-sided specimens were larger than left-sided ones (P = 0.003). Microscopically, ages of thrombi were uniform in 72% and variable in 28%. Intima was thickened in all patients and consisted of collagen (100%), elastin (67%), hemosiderin (56%), inflammation (53%), atherosclerosis (32%), and calcification (15%). We determined that pulmonary thromboendarterectomy was performed most often in middle-aged and elderly patients with a history of deep venous thrombosis or pulmonary embolism. Less than 50% of the patients had an identifiable coagulation, autoimmune, or hematologic abnormality. Most patients had bilateral disease and resections. Right-sided specimens were significantly larger than left-sided specimens, and lower lobe involvement was more common than involvement elsewhere. Resected tissues most commonly exhibited old organized thrombus.

Entities:  

Mesh:

Year:  2003        PMID: 14691915     DOI: 10.1016/j.humpath.2003.07.003

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  21 in total

1.  Intermittent hypoxia and hypercapnia induce pulmonary artery atherosclerosis and ventricular dysfunction in low density lipoprotein receptor deficient mice.

Authors:  Robert M Douglas; Karen Bowden; Jennifer Pattison; Alexander B Peterson; Joseph Juliano; Nancy D Dalton; Yusu Gu; Erika Alvarez; Toshihiro Imamura; Kirk L Peterson; Joseph L Witztum; Gabriel G Haddad; Andrew C Li
Journal:  J Appl Physiol (1985)       Date:  2013-08-29

2.  Left ventricular strain and strain rate by 2D speckle tracking in chronic thromboembolic pulmonary hypertension before and after pulmonary thromboendarterectomy.

Authors:  Nicholas Olson; Jason P Brown; Andrew M Kahn; William R Auger; Michael M Madani; Thomas J Waltman; Daniel G Blanchard
Journal:  Cardiovasc Ultrasound       Date:  2010-09-27       Impact factor: 2.062

Review 3.  Chronic thromboembolic pulmonary hypertension (CTEPH).

Authors:  Keith McNeil; John Dunning
Journal:  Heart       Date:  2007-09       Impact factor: 5.994

Review 4.  Pulmonary hypertension associated with antiphospholipid antibody: Call for a screening tool?

Authors:  Rukma Parthvi; Rutuja R Sikachi; Abhinav Agrawal; Ajay Adial; Abhinav Vulisha; Sameer Khanijo; Arunabh Talwar
Journal:  Intractable Rare Dis Res       Date:  2017-08

5.  A more aggressive approach to emergency embolectomy for acute pulmonary embolism.

Authors:  Basar Sareyyupoglu; Kevin L Greason; Rakesh M Suri; Mark T Keegan; Joseph A Dearani; Thoralf M Sundt
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

Review 6.  Chronic pulmonary embolism: diagnosis.

Authors:  Katia Hidemi Nishiyama; Sachin S Saboo; Yuki Tanabe; Dany Jasinowodolinski; Michael J Landay; Fernando Uliana Kay
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

7.  Pulmonary vascular remodeling before and after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a cardiac magnetic resonance study.

Authors:  Andreas Rolf; Johannes Rixe; Won K Kim; Stefan Guth; Nils Körlings; Helge Möllmann; Holger M Nef; Christoph Liebetrau; Gabriele Krombach; Thorsten Kramm; Eckhard Mayer; Christian W Hamm
Journal:  Int J Cardiovasc Imaging       Date:  2014-12-18       Impact factor: 2.357

8.  Identification of putative endothelial progenitor cells (CD34+CD133+Flk-1+) in endarterectomized tissue of patients with chronic thromboembolic pulmonary hypertension.

Authors:  Weijuan Yao; Amy L Firth; Richard S Sacks; Aiko Ogawa; William R Auger; Peter F Fedullo; Michael M Madani; Grace Y Lin; Naohide Sakakibara; Patricia A Thistlethwaite; Stuart W Jamieson; Lewis J Rubin; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-03-13       Impact factor: 5.464

Review 9.  Current concepts in the pathogenesis of chronic thromboembolic pulmonary hypertension.

Authors:  Daniel T Matthews; Anna R Hemnes
Journal:  Pulm Circ       Date:  2016-06       Impact factor: 3.017

10.  Evaluation of the Incidence of Chronic Thromboembolic Pulmonary Hypertension 1 Year After First Episode of Acute Pulmonary Embolism: A Cohort Study.

Authors:  Farid Rashidi; Rezayat Parvizi; Eisa Bilejani; Babak Mahmoodian; Fatemeh Rahimi; Ata Koohi
Journal:  Lung       Date:  2020-01-02       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.